Best Way to Download Protein Family Sequences From Plant Species

© The Dna Universe/istockphoto/KJN

On the Dark Horse Podcast, Dr. Robert Malone, creator of mRNA vaccine technology, said the COVID vaccine lipid nanoparticles — which tell the torso to produce the spike poly peptide — leave the injection site and accumulate in organs and tissues.

On June 10, Dr. Robert Malone, creator of mRNA vaccine engineering science, joined evolutionary biologist Bret Weinstein, Ph.D., for a iii-hour chat on the Dark Horse Podcast to talk over multiple safe concerns related to the Pfizer and Moderna vaccines.

In this curt outtake from the full podcast, Malone, Weinstein and tech entrepreneur Steve Kirsch touch on the implications of the controversial Japanese Pfizer biodistribution report . The study was fabricated public before this month by Dr. Byram Determent, a viral immunologist.

They besides discuss the lack of proper animal studies for the new mRNA vaccines, and the theory , consort by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce ever more transmissible and potentially deadly variants.

As The Defender reported June three, Bridle received a copy of a Japanese biodistribution study — which had been kept from the public — as a result of a freedom of data request made to the Japanese regime for Pfizer data.

Prior to the study's disclosure, the public was led to believe past regulators and vaccine developers that the spike protein produced by mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically active — even though regulators effectually the world had a copy of the study which showed otherwise.

The biodistribution study obtained past Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid musculus where they were injected as the vaccine'due south developers claimed would happen, but circulated throughout the body and accum ulated in big concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and — in "quite high concentrations" — in the ovaries.

The mRNA — or messenger RNA — is what tells the torso to manufacture the spike poly peptide. The lipid nanoparticles are like the "boxes" the mRNA is shipped in, according to Malone. "If you detect lipid nanoparticles in an organ or tissue, that tells y'all the drug got to that location," Malone explained.

According to the data in the Japanese study, lipid nanoparticles were institute in the whole blood circulating throughout the body within 4 hours, and so settled in big concentrations in the ovaries, bone marrow and lymph nodes.

Malone said there needed to exist monitoring of vaccine recipients for leukemia and lymphomas every bit there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signals oft don't show up for six months to nine years down the road, he said.

Ordinarily, signals like this are picked upward in animal studies and long-term clinical trials, only this didn't happen with mRNA vaccines, Malone said. At that place are 2 adverse event signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). 1 of them is thrombocytopenia — not having enough platelets, which are manufactured in the bone marrow. The other is reactivation of latent viruses.

Malone found the ovarian signal perplexing because at that place is no aggregating in the testes.

Malone said the original data packages contained this biodistribution information. "This data has been out at that place a long time" within the protected, not-disclosed, purview of the regulators across the world, he said.

According to Malone, the FDA knew the COVID spike protein was biologically active and could travel from the injection site and crusade adverse events, and that the spike protein, if biologically agile, is very dangerous.

In fact, Malone was ane of many scientists to warn the FDA nearly the dangers of the costless spike poly peptide.

Malone suggested autoimmune bug may be related to free-circulating spike protein which developers assured would not happen. To pick up autoimmune problems, a two- to 3- year follow-upwardly period in phase three patients would exist required to monitor for potential autoimmune consequences from vaccines — simply that monitoring didn't happen with the Pfizer and Moderna vaccines.

Pfizer and Moderna also didn't conduct proper animal studies, Weinstein said. What the animal models give united states of america is a bespeak that alerts united states to what we need to follow upward on in humans. Weinstein said:

"We've got very alarming short-term stuff. We've got short-term stuff that is alarming on the basis of where nosotros find these lipids, where we detect the spike proteins — those things are reasons for business concern because it wasn't supposed to be this style. We've also got an alarming point in terms of the hazards and deaths or the harms and the deaths that are reported in the system and there are reasons to think they are dramatic under-reports."

Vaden Bossche got it correct

One of the potential harms from the vaccines, Weinstein said, was made famous past Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, Bill & Melinda Gates Foundation'due south Global Health Discovery squad in Seattle, and Global Alliance for Vaccines and Immunization in Geneva.

Earlier this yr, Vanden Bossche put out a phone call to the World Health Arrangement, supported by a 12-folio document , that described the "uncontrollable monster" that a global mass vaccination campaign could potentially unleash.

Vanden Bossche said a combination of lockdowns, and extreme selection pressure level on the virus induced by the intense global mass vaccination program, might diminish the number of cases, hospitalizations and deaths in the short-term, only ultimately, will induce the creation of more than mutants of business organisation. This is what Vanden Bossche calls "immune escape" (i.e. incomplete sterilization of the virus by the human immune system, even following vaccine administration).

Immune escape will in turn trigger vaccine companies to further refine vaccines that volition add, not reduce, the selection force per unit area, producing e'er more transmissible and potentially deadly variants.

The selection pressure volition cause greater convergence in mutations that affect the critical spike poly peptide of the virus that is responsible for breaking through the mucosal surfaces of our airways, the route used by the virus to enter the man trunk.

The virus will finer outsmart the highly specific antigen-based vaccines being used and tweaked, depending on the circulating variants. All of this could lead to a hockey stick-like increase in serious and potentially lethal cases — in consequence, an out-of-command pandemic.

Malone said:

"Vanden Bossche's business is not theoretical. It is real and nosotros take the information. We're stuck with this virus or its downstream variants pretty much for the residual of our lives and it'southward going to become more like the flu. We will have continuing evolution and apportionment of variants, and that is an escape."

DOWNLOAD HERE

Posted by: donnaphroodession.blogspot.com